oxotremorine m has been researched along with xanomeline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goodhead, LH; Mitchell, SN; Moss, S; Sharott, A | 1 |
| Clarke, S; Reed, H; Sher, E; Zwart, R | 1 |
2 other study(ies) available for oxotremorine m and xanomeline
| Article | Year |
|---|---|
Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens.
Topics: Animals; Atropine; Bicuculline; Bridged-Ring Compounds; Carbachol; Cholinergic Agonists; Diamines; Dopamine; Hippocampus; Male; Microdialysis; Muscarinic Agonists; Muscarinic Antagonists; Nicotine; Nucleus Accumbens; Oxotremorine; Pilocarpine; Pyridines; Rats; Receptors, Muscarinic; Spiro Compounds; Thiadiazoles; Tropanes | 2003 |
A novel muscarinic receptor-independent mechanism of KCNQ2/3 potassium channel blockade by Oxotremorine-M.
Topics: Animals; Humans; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Oxotremorine; Potassium Channel Blockers; Pyridines; Receptor, Muscarinic M1; Thiadiazoles; Xenopus | 2016 |